OBJECTIVE: To better understand the clinical spectrum and course of congenital Zika syndrome (CZS) during the first 18 months of life of children whose mothers had rash during pregnancy. METHODS: This longitudinal observational study evaluated the clinical progress from birth until 18 months of life of children of mothers who developed rash during or up to 3 months before gestation. Maternal rash occurred from November 2015 to May 2017. The study subjects were divided into three groups: children whose mothers tested positive by RT-qPCR for Zika virus (ZIKV) (Group 1), children whose mothers tested negative by RT-qPCR for ZIKV (Group 2), and children whose mothers did not undergo any testing for ZIKV (Group 3) but tested negative for other congenital infections. RESULTS: Between April 2016 and July 2018, we studied 108 children: 43 in Group 1, 26 in Group 2 and 39 in Group 3. The majority of children were admitted into the study within 6 months of life. CZS was diagnosed in 26 children, equally distributed in Groups 1 and 3. Of 18 children with microcephaly, 6 were in Group 1 (1 postnatal) and 12 were in Group 3 (5 postnatal). Maternal rash frequency was 10 times higher during the first trimester than in the other trimesters (OR: 10.35; CI 95%: 3.52-30.41). CZS was diagnosed during the follow-up period in 14 (54%) cases. Developmental delays and motor abnormalities occurred in all children and persisted up to 18 months. Epilepsy occurred in 18 (69%) of the cases. CONCLUSIONS: Infants born of mothers exposed to ZIKV during pregnancy showed progression of developmental, motor and neurologic abnormalities even if they were born asymptomatic. Continued postnatal monitoring of such newborns is necessary to preclude disability-associated complications.
OBJECTIVE: To better understand the clinical spectrum and course of congenital Zika syndrome (CZS) during the first 18 months of life of children whose mothers had rash during pregnancy. METHODS: This longitudinal observational study evaluated the clinical progress from birth until 18 months of life of children of mothers who developed rash during or up to 3 months before gestation. Maternal rash occurred from November 2015 to May 2017. The study subjects were divided into three groups: children whose mothers tested positive by RT-qPCR for Zika virus (ZIKV) (Group 1), children whose mothers tested negative by RT-qPCR for ZIKV (Group 2), and children whose mothers did not undergo any testing for ZIKV (Group 3) but tested negative for other congenital infections. RESULTS: Between April 2016 and July 2018, we studied 108 children: 43 in Group 1, 26 in Group 2 and 39 in Group 3. The majority of children were admitted into the study within 6 months of life. CZS was diagnosed in 26 children, equally distributed in Groups 1 and 3. Of 18 children with microcephaly, 6 were in Group 1 (1 postnatal) and 12 were in Group 3 (5 postnatal). Maternal rash frequency was 10 times higher during the first trimester than in the other trimesters (OR: 10.35; CI 95%: 3.52-30.41). CZS was diagnosed during the follow-up period in 14 (54%) cases. Developmental delays and motor abnormalities occurred in all children and persisted up to 18 months. Epilepsy occurred in 18 (69%) of the cases. CONCLUSIONS:Infants born of mothers exposed to ZIKV during pregnancy showed progression of developmental, motor and neurologic abnormalities even if they were born asymptomatic. Continued postnatal monitoring of such newborns is necessary to preclude disability-associated complications.
Authors: Hélio van der Linden; Maria D Carvalho; Vanessa van der Linden; Kalyne M Lacerda; André Pessoa; Mara L Carneiro; Marli T Cordeiro; Kette D Valente Journal: N Engl J Med Date: 2018-08-30 Impact factor: 91.245
Authors: André Pessoa; Vanessa van der Linden; Marshalyn Yeargin-Allsopp; Maria Durce Costa Gomes Carvalho; Erlane Marques Ribeiro; Kim Van Naarden Braun; Maureen S Durkin; Daniel M Pastula; Jazmyn T Moore; Cynthia A Moore Journal: Pediatrics Date: 2018-02-01 Impact factor: 7.124
Authors: M L Nogueira; N R R Nery Júnior; C F Estofolete; A C Bernardes Terzian; G F Guimarães; N Zini; R Alves da Silva; G C Dutra Silva; L C Junqueira Franco; P Rahal; C Bittar; B Carneiro; P F C Vasconcelos; D Freitas Henriques; D M U Barbosa; P Lopes Rombola; L de Grande; A F Negri Reis; S A Palomares; M Wakai Catelan; L E A A Cruz; S H Necchi; R C V Mendonça; I N Penha Dos Santos; S B Alavarse Caron; F Costa; F A Bozza; A Soares de Souza; C C Brandão de Mattos; L C de Mattos; N Vasilakis; A H Oliani; D C M Vaz Oliani; A I Ko Journal: Clin Microbiol Infect Date: 2017-11-10 Impact factor: 8.067
Authors: Cynthia A Moore; J Erin Staples; William B Dobyns; André Pessoa; Camila V Ventura; Eduardo Borges da Fonseca; Erlane Marques Ribeiro; Liana O Ventura; Norberto Nogueira Neto; J Fernando Arena; Sonja A Rasmussen Journal: JAMA Pediatr Date: 2017-03-01 Impact factor: 16.193
Authors: J Villar; D G Altman; M Purwar; J A Noble; H E Knight; P Ruyan; L Cheikh Ismail; F C Barros; A Lambert; A T Papageorghiou; M Carvalho; Y A Jaffer; E Bertino; M G Gravett; Z A Bhutta; S H Kennedy Journal: BJOG Date: 2013-05-17 Impact factor: 6.531
Authors: Giovanny V A França; Lavinia Schuler-Faccini; Wanderson K Oliveira; Claudio M P Henriques; Eduardo H Carmo; Vaneide D Pedi; Marília L Nunes; Marcia C Castro; Suzanne Serruya; Mariângela F Silveira; Fernando C Barros; Cesar G Victora Journal: Lancet Date: 2016-06-29 Impact factor: 79.321
Authors: Patrick K Mitchell; Luis Mier-Y-Teran-Romero; Brad J Biggerstaff; Mark J Delorey; Maite Aubry; Van-Mai Cao-Lormeau; Matthew J Lozier; Simon Cauchemez; Michael A Johansson Journal: Am J Epidemiol Date: 2019-01-01 Impact factor: 4.897
Authors: Thaís Lorena Barbosa de França; Wilton Rodrigues Medeiros; Nilba Lima de Souza; Egmar Longo; Silvana Alves Pereira; Thamyris Barbosa de Oliveira França; Klayton Galante Sousa Journal: Int J Environ Res Public Health Date: 2018-09-13 Impact factor: 3.390
Authors: Elena Marbán-Castro; Laia J Vazquez Guillamet; Percy Efrain Pantoja; Aina Casellas; Lauren Maxwell; Sarah B Mulkey; Clara Menéndez; Azucena Bardají Journal: Int J Environ Res Public Health Date: 2022-06-14 Impact factor: 4.614
Authors: Alexandra P Key; Silvia F B de Moura Negrini; Carla A C Tanuri Caldas; Sara Reis Teixeira; Adriana R T Anastasio; Juliana Cavalcante; Marisa M Mussi-Pinhata; Linda J Hood Journal: Early Hum Dev Date: 2021-09-15 Impact factor: 2.079
Authors: Ivan Trus; Daniel Udenze; Brian Cox; Nathalie Berube; Rebecca E Nordquist; Franz Josef van der Staay; Yanyun Huang; Gary Kobinger; David Safronetz; Volker Gerdts; Uladzimir Karniychuk Journal: PLoS Pathog Date: 2019-11-14 Impact factor: 6.823
Authors: Livia Rosa-Fernandes; Raquel Hora Barbosa; Maria Luiza B Dos Santos; Claudia B Angeli; Thiago P Silva; Rossana C N Melo; Gilberto Santos de Oliveira; Bernardo Lemos; Jennifer E Van Eyk; Martin R Larsen; Claudete Araújo Cardoso; Giuseppe Palmisano Journal: J Proteome Res Date: 2020-08-04 Impact factor: 4.466
Authors: Janaina Macedo-da-Silva; Lívia Rosa-Fernandes; Raquel Hora Barbosa; Claudia B Angeli; Fabiana Rabe Carvalho; Renata Artimos de Oliveira Vianna; Paulo C Carvalho; Martin R Larsen; Claudete Araújo Cardoso; Giuseppe Palmisano Journal: Front Cell Infect Microbiol Date: 2020-11-18 Impact factor: 5.293
Authors: Leão Vhp; M M Aragão; R S Pinho; A N Hazin; A R Paciorkowski; A C Penalva de Oliveira; Marcelo Rodrigues Masruha Journal: Curr Neurol Neurosci Rep Date: 2020-09-03 Impact factor: 5.081
Authors: Michelle R Koenig; Elaina Razo; Ann Mitzey; Christina M Newman; Dawn M Dudley; Meghan E Breitbach; Matthew R Semler; Laurel M Stewart; Andrea M Weiler; Sierra Rybarczyk; Kathryn M Bach; Mariel S Mohns; Heather A Simmons; Andres Mejia; Michael Fritsch; Maria Dennis; Leandro B C Teixeira; Michele L Schotzko; T Michael Nork; Carol A Rasmussen; Alex Katz; Veena Nair; Jiancheng Hou; Amy Hartman; James Ver Hoeve; Charlene Kim; Mary L Schneider; Karla Ausderau; Sarah Kohn; Anna S Jaeger; Matthew T Aliota; Jennifer M Hayes; Nancy Schultz-Darken; Jens Eickhoff; Kathleen M Antony; Kevin Noguchi; Xiankun Zeng; Sallie Permar; Vivek Prabhakaran; Saverio Capuano; Thomas C Friedrich; Thaddeus G Golos; David H O'Connor; Emma L Mohr Journal: PLoS One Date: 2020-10-22 Impact factor: 3.752